OUR STORY

Our story began in 2017, in Lebanon, after being made aware of the lack of access to treatment options for low-income patients diagnosed with neurodegenerative disorders.

Even with access to the best of care and treatment options, neurodegenerative disorders, such as Parkinson’s disease, Lewy Body dementia, and multiple sclerosis are particularly difficult to manage. They come with a wide range of debilitating movement and non-movement symptoms, and they have no cure. Without access to basic treatment options, a person’s quality of life becomes severely impacted.

Our journey was inspired by the simple desire to offer some type of relief to fellow human beings. Working hand in hand with neurologists based in Lebanon, we started funding treatments for those who could not afford the basic medication needed to maintain their dignity and a decent quality of life.


Today, our reach has extended beyond the Middle East into Africa. In partnership with Parkinson’s Africa – an organisation established to support and empower Africans affected by Parkinson’s disease – we are currently funding medication for hundreds of Nigerian patients.
Currently, the foundation wishes to broaden its scope to reach more people in need of treatment in Lebanon, Nigeria, Senegal and anywhere in the world.

Provide free medication to low-income patients in developing countries who are affected by Parkinson’s disease and other neurological disorders.

Under the best sets of circumstances, with access to healthcare and treatment options, complex neurological disorders like Parkinson’s disease are particularly difficult to manage and deal with. In addition to the movement symptoms that severely impact a person’s mobility and daily functions, there are multiple, equally debilitating non-movement symptoms (pain, fatigue, anxiety, and depression) to contend with.

DISCOVER OUR MISSION

Our vision

The Farah Foundation is dedicated to removing that added layer of burden, and to driving change within countries where access to medical treatment is limited. We have set out to give a hand to families otherwise abandoned to their own fate in the face of neurological diseases.